Clinical Trial Update: A Study Assessing Safety and Effectiveness of BORTEZOMIB Combination Therapy (Bortezomib + Doxorubicin Hydrochloride + Dexamethasone) in Previously Untreated Multiple Myeloma Patients [Phase 2]

View source ↗

Summary

Phase 2 trial update reports safety and effectiveness results for a bortezomib-based combination (bortezomib + doxorubicin hydrochloride + dexamethasone) in pat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Bortezomib (bortezomib)
• DEXAMETHASONE (Dexamethasone)
• DOXORUBICIN HYDROCHLORIDE (Doxorubicin hydrochloride)

Snippet

Sponsor: Janssen-Ortho Inc., Canada | Conditions: Multiple Myeloma | Phase 2 | Status: COMPLETED